- Home
- BWLP vs IMCR Comparison
BWLP vs IMCR Comparison
Compare BWLP & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- IMCR
- Stock Information
- Founded
- BWLP 1935
- IMCR 2008
- Country
- BWLP Singapore
- IMCR United Kingdom
- Employees
- BWLP N/A
- IMCR N/A
- Industry
- BWLP Marine Transportation
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWLP Consumer Discretionary
- IMCR Health Care
- Exchange
- BWLP Nasdaq
- IMCR Nasdaq
- Market Cap
- BWLP 1.9B
- IMCR 1.7B
- IPO Year
- BWLP N/A
- IMCR 2021
- Fundamental
- Price
- BWLP $12.76
- IMCR $32.93
- Analyst Decision
- BWLP
- IMCR Buy
- Analyst Count
- BWLP 0
- IMCR 14
- Target Price
- BWLP N/A
- IMCR $74.75
- AVG Volume (30 Days)
- BWLP 255.5K
- IMCR 267.8K
- Earning Date
- BWLP 01-01-0001
- IMCR 11-05-2024
- Dividend Yield
- BWLP 24.68%
- IMCR N/A
- EPS Growth
- BWLP 43.64
- IMCR N/A
- EPS
- BWLP 3.64
- IMCR N/A
- Revenue
- BWLP $3,510,244,000.00
- IMCR $280,914,000.00
- Revenue This Year
- BWLP N/A
- IMCR $25.60
- Revenue Next Year
- BWLP N/A
- IMCR $10.63
- P/E Ratio
- BWLP $3.68
- IMCR N/A
- Revenue Growth
- BWLP 57.96
- IMCR 27.95
- 52 Week Low
- BWLP $10.32
- IMCR $29.72
- 52 Week High
- BWLP $22.31
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- BWLP 33.59
- IMCR 52.76
- Support Level
- BWLP $13.21
- IMCR $31.10
- Resistance Level
- BWLP $13.58
- IMCR $35.47
- Average True Range (ATR)
- BWLP 0.23
- IMCR 1.49
- MACD
- BWLP -0.15
- IMCR 0.17
- Stochastic Oscillator
- BWLP 2.94
- IMCR 51.98
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.